SCHEMBL9874920

SCHEMBL9874920

CN(CC(=O)Nc1ccc(Cl)cc1)c1c(C(=O)c2ccccc2)cnc2cccnc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
KMT2A Q03164 5/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 3/20 0.41
NOTUM Q6P988 1/20 0.41
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
POLB P06746 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
TSHR P16473 1/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9874916 0.79 SMN1; SMN2 (0.42) TDP1KMT2ANPC1RAB9AMEN1
SCHEMBL9879839 0.75 LMNA (0.41) TDP1KMT2ANPC1RAB9AMEN1
SCHEMBL9381137 0.73 GABRP (0.39) TDP1KMT2ANPC1RAB9AMEN1
SCHEMBL9873674 0.71 KMT2A (0.42) KMT2AMEN1LMNACYP1A2CYP2C9
SCHEMBL9874472 0.71 SMN1; SMN2 (0.37) KMT2ANPC1RAB9AMEN1CYP1A2
SCHEMBL9872674 0.68 ALDH1A1 (0.45) KMT2ANPC1RAB9AMEN1LMNA
SCHEMBL11658582 0.64 SMN1; SMN2 (0.60) KMT2AMEN1LMNACYP1A2CYP2C9
SCHEMBL17963199 0.64 ALDH1A1 (0.79) KMT2ANPC1RAB9AMEN1LMNA
SCHEMBL9874474 0.64 SMN1; SMN2 (0.41) TDP1KMT2AMEN1LMNAL3MBTL1
SCHEMBL11654865 0.63 SMN1; SMN2 (0.58) KMT2AMEN1LMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026711-A Prevention and treatment of cardiovascular disorders and infections states; anxiolytic and anti-allergic agents SANOFI (FR) 1991-06-25 US disclosed